Bausch Health is rumored to be looking to sell its Bausch + Lomb business, which will ease bankruptcy concerns and upgrade ...

Hedge fund managers sit on the boards of Bausch Health and Bausch + Lomb. They don’t think like your typical corporate board, ...

While we all hope that businesses large and small are out in the world doing the best job possible to be scandal-free, it’s ...

Valeant helped found Philidor in 2013, and most of the drugs it dispensed were from Valeant. Prosecutors alleged Tanner passed inside information to Davenport to bolster Philidor's business.

Who was I to question their proven wisdom? What I didn’t know: Valeant was no Berkshire Hathaway. Sequoia did well for four years after I first recommended it. From August 31, 2011, through ...

Bausch + Lomb was put up for sale after a planned separation from its parent company Bausch Health, formerly known as Valeant ...

Shares of Bausch + Lomb (NYSE: BLCO) rallied 15.7% as of 3:07 p.m. ET today. The stock is surging today on news the company ...

Andrew Left is fighting a range of criminal and civil charges related to his trading practices, and other investors who make ...

Valeant's takeover bid for Allergan has been once again rejected by the company's board - which has used increasingly vivid language to dismiss the unwanted advances. Valeant and its 'activist ...

本次传出出售博士伦的消息，或许与博士康的当下困境密不可分。据报道，博士康现有债务为210亿美元，其中100亿美元将在2027年底前到期。然而由于博士伦是重要的创收子公司，母公司必须通过偿付能力测试，然后才能批准出售。

© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...

So if you see this the way Allergan does Valeant has every reason to want this deal done as soon as possible. Valeant doesn't want Bausch & Lomb to disappoint. Besides making Allergan shareholders ...